Cash Flow Santen Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
48,166.00
37,449.00
-3,437.00
37,220.00
12,046.00
32,091.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
5,800.00
15,701.00
-6,460.00
1,854.00
-18,484.00
-392.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
60,928.00
72,649.00
37,147.00
46,043.00
38,808.00
39,947.00
Cash Flow from Investing Activities
-8,223.00
-6,145.00
-26,777.00
-35,169.00
-53,355.00
-5,175.00
Cash Flow from Financing Activities
-53,307.00
-34,031.00
-37,220.00
5,557.00
-16,685.00
-12,729.00
Net Cash Inflow / Outflow
-1,585.00
36,679.00
-25,111.00
20,125.00
-28,542.00
20,633.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-983.00
4,206.00
1,739.00
3,694.00
2,690.00
-1,410.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Santen Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
48166
13914
34,252.00
246.17%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
5800
-2612
8,412.00
322.05%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
60928
11246
49,682.00
441.77%
Cash Flow from Investing Activities
-8223
-18415
10,192.00
55.35%
Cash Flow from Financing Activities
-53307
-7768
-45,539.00
-586.24%
Net Cash Inflow / Outflow
-1585
-13717
12,132.00
88.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-983
1220
-2,203.00
-180.57%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -16.13% vs 95.57% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
60,928.00
72,649.00
-16.13%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
